Table 3 Baseline characteristics by 3%ODI (≤ 59 years old).
From: Sleep-disordered breathing profiles in patients with cardiovascular diseases: Kurume SDB-CVD study
Total | 3%ODI < 5 | 5 ≤ 3%ODI < 15 | 15 ≤ 3%ODI < 30 | 30 ≤ 3%ODI | P for trend |
|---|---|---|---|---|---|
n (%) | 736 (50.2) | 539 (36.8) | 143 (9.8) | 47(3.2) | |
Male/Female (Male,%) | 403/333 (54.8) | 359/180 (66.6) | 115/28 (80.4) | 39/8 (90.0) | < 0.001 |
SpO2 at awakening, % | 95.5 ± 1.7 | 94.2 ± 2.0 | 93.4 ± 1.7 | 91.6 ± 3.2 | < 0.001 |
Systolic blood pressure, mmHg | 117.9 ± 17.0 | 117.6 ± 19.0 | 122.0 ± 18.1 | 124.7 ± 19.2 | 0.006 |
Diastolic blood pressure, mmHg | 72.8 ± 13.5 | 72.9 ± 13.8 | 74.1 ± 13.3 | 77.5 ± 12.7 | 0.048 |
Pulse pressure, mmHg | 45.1 ± 12.4 | 44.7 ± 13.1 | 47.9 ± 14.2 | 47.2 ± 13.0 | 0.075 |
Pulse rate, bpm | 74.1 ± 13.8 | 74.5 ± 14.0 | 75.2 ± 15.3 | 81.3 ± 14.8 | 0.013 |
BMI, kg/m2 | 22.7 ± 3.8 | 24.4 ± 4.3 | 26.7 ± 5.0 | 30.0 ± 6.3 | < 0.001 |
WBC, /μL | 5804 ± 1822 | 6343 ± 2121 | 6681 ± 2001 | 6920 ± 2793 | < 0.001 |
Hb, g/dL | 13.8 ± 1.9 | 14.0 ± 2.0 | 14.1 ± 2.1 | 14.2 ± 2.3 | 0.006 |
HbA1c, % | 5.7 ± 0.8 | 6.0 ± 0.9 | 6.3 ± 0.9 | 6.7 ± 1.0 | < 0.001 |
Serum creatinin, mg/dL | 0.87 ± 1.07 | 1.03 ± 1.39 | 1.33 ± 2.01 | 1.42 ± 1.93 | < 0.001 |
Serum sodium, mEq/L | 140.7 ± 2.3 | 140.7 ± 2.7 | 141.3 ± 3.1 | 140.7 ± 2.7 | 0.127 |
NT-proBNP, pg/mL | 1074 ± 5177 | 2324 ± 19,100 | 3934 ± 24,151 | 4906 ± 16,786 | 0.008 |
CTR (chest X-ray), % | 47.2 ± 7.0 | 49.6 ± 7.0 | 50.6 ± 6.7 | 52.8 ± 6.2 | < 0.001 |
LVEF, % | 61.7 ± 13.3 | 57.9 ± 16.6 | 55.6 ± 17.0 | 49.7 ± 17.5 | < 0.001 |
